nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Arginine—NOS2—Effects of Nitric Oxide—MB—brain cancer	0.0417	0.18	CbGpPWpGaD
L-Arginine—Edema cerebral—Carmustine—brain cancer	0.0348	0.0909	CcSEcCtD
L-Arginine—Edema cerebral—Temozolomide—brain cancer	0.0336	0.0879	CcSEcCtD
L-Arginine—NOS3—vein—brain cancer	0.0326	0.0893	CbGeAlD
L-Arginine—NOS3—Effects of Nitric Oxide—MB—brain cancer	0.0324	0.14	CbGpPWpGaD
L-Arginine—Skin necrosis—Hydroxyurea—brain cancer	0.019	0.0498	CcSEcCtD
L-Arginine—Brain oedema—Carmustine—brain cancer	0.0188	0.0492	CcSEcCtD
L-Arginine—Brain oedema—Temozolomide—brain cancer	0.0182	0.0476	CcSEcCtD
L-Arginine—Extravasation—Carboplatin—brain cancer	0.0177	0.0464	CcSEcCtD
L-Arginine—Skin necrosis—Carmustine—brain cancer	0.0154	0.0403	CcSEcCtD
L-Arginine—ARG2—hindbrain—brain cancer	0.0141	0.0387	CbGeAlD
L-Arginine—L-Cysteine—MGMT—brain cancer	0.0123	0.592	CrCbGaD
L-Arginine—Skin necrosis—Etoposide—brain cancer	0.0119	0.0311	CcSEcCtD
L-Arginine—AZIN2—pituitary gland—brain cancer	0.0112	0.0307	CbGeAlD
L-Arginine—NOS3—endothelium—brain cancer	0.0112	0.0307	CbGeAlD
L-Arginine—Platelet count decreased—Hydroxyurea—brain cancer	0.0112	0.0293	CcSEcCtD
L-Arginine—AZIN2—medulla oblongata—brain cancer	0.0108	0.0297	CbGeAlD
L-Arginine—NOS3—blood vessel—brain cancer	0.0104	0.0283	CbGeAlD
L-Arginine—Lethargy—Lomustine—brain cancer	0.01	0.0262	CcSEcCtD
L-Arginine—AZIN2—midbrain—brain cancer	0.00991	0.0271	CbGeAlD
L-Arginine—AZIN2—spinal cord—brain cancer	0.00967	0.0265	CbGeAlD
L-Arginine—NOS2—Alpha9 beta1 integrin signaling events—TGM2—brain cancer	0.00943	0.0408	CbGpPWpGaD
L-Arginine—SLC7A4—head—brain cancer	0.00896	0.0245	CbGeAlD
L-Arginine—L-Glutamine—TGM2—brain cancer	0.00849	0.408	CrCbGaD
L-Arginine—SLC7A1—telencephalon—brain cancer	0.00841	0.023	CbGeAlD
L-Arginine—SLC7A4—central nervous system—brain cancer	0.00818	0.0224	CbGeAlD
L-Arginine—ARG2—brainstem—brain cancer	0.0081	0.0222	CbGeAlD
L-Arginine—ASL—endocrine gland—brain cancer	0.00809	0.0221	CbGeAlD
L-Arginine—ASL—head—brain cancer	0.00799	0.0219	CbGeAlD
L-Arginine—AZIN2—cerebellum—brain cancer	0.00767	0.021	CbGeAlD
L-Arginine—ASL—central nervous system—brain cancer	0.00729	0.02	CbGeAlD
L-Arginine—ARG2—telencephalon—brain cancer	0.00719	0.0197	CbGeAlD
L-Arginine—ASL—cerebellum—brain cancer	0.00713	0.0195	CbGeAlD
L-Arginine—SLC7A1—gonad—brain cancer	0.00702	0.0192	CbGeAlD
L-Arginine—Necrosis—Carmustine—brain cancer	0.00685	0.0179	CcSEcCtD
L-Arginine—SLC7A4—brain—brain cancer	0.00649	0.0178	CbGeAlD
L-Arginine—Lethargy—Procarbazine—brain cancer	0.00637	0.0167	CcSEcCtD
L-Arginine—Skin exfoliation—Hydroxyurea—brain cancer	0.00635	0.0166	CcSEcCtD
L-Arginine—SLC7A3—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.00626	0.027	CbGpPWpGaD
L-Arginine—AZIN2—brain—brain cancer	0.00623	0.017	CbGeAlD
L-Arginine—Extravasation—Carmustine—brain cancer	0.00616	0.0161	CcSEcCtD
L-Arginine—ARG2—gonad—brain cancer	0.006	0.0164	CbGeAlD
L-Arginine—ARG2—pituitary gland—brain cancer	0.00586	0.016	CbGeAlD
L-Arginine—ASL—brain—brain cancer	0.00579	0.0158	CbGeAlD
L-Arginine—ARG2—medulla oblongata—brain cancer	0.00565	0.0155	CbGeAlD
L-Arginine—SLC7A3—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.00558	0.0241	CbGpPWpGaD
L-Arginine—Injection site reaction—Carmustine—brain cancer	0.00535	0.014	CcSEcCtD
L-Arginine—SLC7A1—endocrine gland—brain cancer	0.0053	0.0145	CbGeAlD
L-Arginine—Necrosis—Etoposide—brain cancer	0.0053	0.0139	CcSEcCtD
L-Arginine—SLC7A1—head—brain cancer	0.00524	0.0143	CbGeAlD
L-Arginine—ARG2—midbrain—brain cancer	0.00516	0.0141	CbGeAlD
L-Arginine—Skin exfoliation—Carmustine—brain cancer	0.00514	0.0134	CcSEcCtD
L-Arginine—ASS1—telencephalon—brain cancer	0.00504	0.0138	CbGeAlD
L-Arginine—ARG2—spinal cord—brain cancer	0.00504	0.0138	CbGeAlD
L-Arginine—NOS3—telencephalon—brain cancer	0.00502	0.0137	CbGeAlD
L-Arginine—Numbness—Etoposide—brain cancer	0.00502	0.0131	CcSEcCtD
L-Arginine—Skin exfoliation—Temozolomide—brain cancer	0.00496	0.013	CcSEcCtD
L-Arginine—Sensory loss—Etoposide—brain cancer	0.0048	0.0126	CcSEcCtD
L-Arginine—SLC7A1—central nervous system—brain cancer	0.00478	0.0131	CbGeAlD
L-Arginine—Extravasation—Etoposide—brain cancer	0.00477	0.0125	CcSEcCtD
L-Arginine—NOS3—SHP2 signaling—NTRK3—brain cancer	0.00467	0.0202	CbGpPWpGaD
L-Arginine—SLC7A1—cerebellum—brain cancer	0.00467	0.0128	CbGeAlD
L-Arginine—Sweating—Procarbazine—brain cancer	0.00461	0.0121	CcSEcCtD
L-Arginine—Anorexia—Lomustine—brain cancer	0.00461	0.012	CcSEcCtD
L-Arginine—Haematuria—Procarbazine—brain cancer	0.00459	0.012	CcSEcCtD
L-Arginine—ARG2—endocrine gland—brain cancer	0.00454	0.0124	CbGeAlD
L-Arginine—ARG2—head—brain cancer	0.00448	0.0123	CbGeAlD
L-Arginine—Swelling—Carmustine—brain cancer	0.00443	0.0116	CcSEcCtD
L-Arginine—ASS1—gonad—brain cancer	0.00421	0.0115	CbGeAlD
L-Arginine—Decreased appetite—Lomustine—brain cancer	0.0042	0.011	CcSEcCtD
L-Arginine—ASS1—pituitary gland—brain cancer	0.0041	0.0112	CbGeAlD
L-Arginine—ARG2—central nervous system—brain cancer	0.00409	0.0112	CbGeAlD
L-Arginine—Flushing—Procarbazine—brain cancer	0.00401	0.0105	CcSEcCtD
L-Arginine—ARG2—cerebellum—brain cancer	0.00399	0.0109	CbGeAlD
L-Arginine—Skin exfoliation—Etoposide—brain cancer	0.00397	0.0104	CcSEcCtD
L-Arginine—ASS1—medulla oblongata—brain cancer	0.00396	0.0108	CbGeAlD
L-Arginine—SLC7A3—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.00391	0.0169	CbGpPWpGaD
L-Arginine—NOS3—Thromboxane A2 receptor signaling—TGM2—brain cancer	0.00384	0.0166	CbGpPWpGaD
L-Arginine—SLC7A1—brain—brain cancer	0.00379	0.0104	CbGeAlD
L-Arginine—ASS1—midbrain—brain cancer	0.00362	0.00991	CbGeAlD
L-Arginine—ASS1—spinal cord—brain cancer	0.00353	0.00966	CbGeAlD
L-Arginine—NOS2—Alpha9 beta1 integrin signaling events—SPP1—brain cancer	0.00349	0.0151	CbGpPWpGaD
L-Arginine—Swelling—Etoposide—brain cancer	0.00342	0.00895	CcSEcCtD
L-Arginine—ARG2—brain—brain cancer	0.00324	0.00888	CbGeAlD
L-Arginine—ASS1—endocrine gland—brain cancer	0.00318	0.0087	CbGeAlD
L-Arginine—NOS3—endocrine gland—brain cancer	0.00317	0.00867	CbGeAlD
L-Arginine—ASS1—head—brain cancer	0.00314	0.00859	CbGeAlD
L-Arginine—NOS3—head—brain cancer	0.00313	0.00856	CbGeAlD
L-Arginine—NOS3—VEGFR2 mediated vascular permeability—VAV1—brain cancer	0.00311	0.0135	CbGpPWpGaD
L-Arginine—Vomiting—Lomustine—brain cancer	0.00307	0.00803	CcSEcCtD
L-Arginine—SLC16A10—gonad—brain cancer	0.003	0.00822	CbGeAlD
L-Arginine—Tachycardia—Procarbazine—brain cancer	0.00299	0.00783	CcSEcCtD
L-Arginine—Hyperhidrosis—Procarbazine—brain cancer	0.00297	0.00776	CcSEcCtD
L-Arginine—NOS3—PAR1-mediated thrombin signaling events—TRPC6—brain cancer	0.00295	0.0127	CbGpPWpGaD
L-Arginine—Anorexia—Procarbazine—brain cancer	0.00292	0.00765	CcSEcCtD
L-Arginine—NOS3—Angiogenesis—PDGFRA—brain cancer	0.00289	0.0125	CbGpPWpGaD
L-Arginine—Nausea—Lomustine—brain cancer	0.00287	0.00751	CcSEcCtD
L-Arginine—ASS1—central nervous system—brain cancer	0.00286	0.00784	CbGeAlD
L-Arginine—NOS3—central nervous system—brain cancer	0.00286	0.00781	CbGeAlD
L-Arginine—ASS1—cerebellum—brain cancer	0.0028	0.00766	CbGeAlD
L-Arginine—Hypoaesthesia—Carmustine—brain cancer	0.00269	0.00703	CcSEcCtD
L-Arginine—Decreased appetite—Procarbazine—brain cancer	0.00267	0.00697	CcSEcCtD
L-Arginine—SLC22A4—pituitary gland—brain cancer	0.00261	0.00715	CbGeAlD
L-Arginine—Hypoaesthesia—Temozolomide—brain cancer	0.0026	0.00679	CcSEcCtD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—ESR2—brain cancer	0.00254	0.011	CbGpPWpGaD
L-Arginine—Flushing—Carmustine—brain cancer	0.00251	0.00656	CcSEcCtD
L-Arginine—Flushing—Temozolomide—brain cancer	0.00242	0.00634	CcSEcCtD
L-Arginine—NOS2—Platelet homeostasis—TRPC6—brain cancer	0.00236	0.0102	CbGpPWpGaD
L-Arginine—ASS1—brain—brain cancer	0.00227	0.00622	CbGeAlD
L-Arginine—SLC16A10—endocrine gland—brain cancer	0.00227	0.00621	CbGeAlD
L-Arginine—NOS3—brain—brain cancer	0.00227	0.0062	CbGeAlD
L-Arginine—Anorexia—Hydroxyurea—brain cancer	0.00226	0.00592	CcSEcCtD
L-Arginine—Hypersensitivity—Procarbazine—brain cancer	0.00226	0.00591	CcSEcCtD
L-Arginine—SLC22A4—spinal cord—brain cancer	0.00225	0.00615	CbGeAlD
L-Arginine—NOS2—Circadian rythm related genes—NTRK3—brain cancer	0.00223	0.00962	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—GFAP—brain cancer	0.00222	0.0096	CbGpPWpGaD
L-Arginine—Hypoaesthesia—Etoposide—brain cancer	0.00208	0.00544	CcSEcCtD
L-Arginine—Decreased appetite—Hydroxyurea—brain cancer	0.00206	0.0054	CcSEcCtD
L-Arginine—SLC16A10—cerebellum—brain cancer	0.002	0.00547	CbGeAlD
L-Arginine—SLC7A1—Transmembrane transport of small molecules—S100A10—brain cancer	0.00198	0.00857	CbGpPWpGaD
L-Arginine—Vomiting—Procarbazine—brain cancer	0.00195	0.0051	CcSEcCtD
L-Arginine—Flushing—Etoposide—brain cancer	0.00194	0.00507	CcSEcCtD
L-Arginine—Rash—Procarbazine—brain cancer	0.00193	0.00506	CcSEcCtD
L-Arginine—Dermatitis—Procarbazine—brain cancer	0.00193	0.00505	CcSEcCtD
L-Arginine—Headache—Procarbazine—brain cancer	0.00192	0.00503	CcSEcCtD
L-Arginine—NOS2—ATF-2 transcription factor network—HES1—brain cancer	0.0019	0.00821	CbGpPWpGaD
L-Arginine—Tachycardia—Carmustine—brain cancer	0.00187	0.0049	CcSEcCtD
L-Arginine—Anaphylactic shock—Temozolomide—brain cancer	0.00185	0.00485	CcSEcCtD
L-Arginine—SLC7A3—Transmembrane transport of small molecules—S100A10—brain cancer	0.00184	0.00796	CbGpPWpGaD
L-Arginine—NOS3—Platelet homeostasis—TRPC6—brain cancer	0.00183	0.00791	CbGpPWpGaD
L-Arginine—Anorexia—Carmustine—brain cancer	0.00183	0.00478	CcSEcCtD
L-Arginine—Nausea—Procarbazine—brain cancer	0.00182	0.00477	CcSEcCtD
L-Arginine—NOS2—ATF-2 transcription factor network—PDGFRA—brain cancer	0.00181	0.00782	CbGpPWpGaD
L-Arginine—Hyperhidrosis—Temozolomide—brain cancer	0.00179	0.00469	CcSEcCtD
L-Arginine—SLC22A4—cerebellum—brain cancer	0.00178	0.00488	CbGeAlD
L-Arginine—Anorexia—Temozolomide—brain cancer	0.00177	0.00462	CcSEcCtD
L-Arginine—Hypersensitivity—Hydroxyurea—brain cancer	0.00175	0.00457	CcSEcCtD
L-Arginine—SLC22A5—pituitary gland—brain cancer	0.00173	0.00473	CbGeAlD
L-Arginine—Decreased appetite—Carmustine—brain cancer	0.00167	0.00436	CcSEcCtD
L-Arginine—NOS2—Alpha9 beta1 integrin signaling events—VEGFA—brain cancer	0.00167	0.00721	CbGpPWpGaD
L-Arginine—SLC22A5—medulla oblongata—brain cancer	0.00167	0.00456	CbGeAlD
L-Arginine—SLC7A3—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	0.00167	0.0072	CbGpPWpGaD
L-Arginine—Decreased appetite—Temozolomide—brain cancer	0.00161	0.00422	CcSEcCtD
L-Arginine—NOS2—IL23-mediated signaling events—RELA—brain cancer	0.00159	0.00688	CbGpPWpGaD
L-Arginine—SLC22A5—midbrain—brain cancer	0.00152	0.00417	CbGeAlD
L-Arginine—Vomiting—Hydroxyurea—brain cancer	0.00151	0.00395	CcSEcCtD
L-Arginine—Rash—Hydroxyurea—brain cancer	0.0015	0.00391	CcSEcCtD
L-Arginine—Dermatitis—Hydroxyurea—brain cancer	0.0015	0.00391	CcSEcCtD
L-Arginine—NOS2—ATF-2 transcription factor network—CDK4—brain cancer	0.00149	0.00644	CbGpPWpGaD
L-Arginine—Headache—Hydroxyurea—brain cancer	0.00149	0.00389	CcSEcCtD
L-Arginine—SLC22A5—spinal cord—brain cancer	0.00149	0.00407	CbGeAlD
L-Arginine—Anaphylactic shock—Etoposide—brain cancer	0.00148	0.00388	CcSEcCtD
L-Arginine—Tachycardia—Etoposide—brain cancer	0.00145	0.00379	CcSEcCtD
L-Arginine—SLC22A4—brain—brain cancer	0.00145	0.00396	CbGeAlD
L-Arginine—Hyperhidrosis—Etoposide—brain cancer	0.00143	0.00375	CcSEcCtD
L-Arginine—NOS2—IL23-mediated signaling events—IL2—brain cancer	0.00143	0.0062	CbGpPWpGaD
L-Arginine—Anorexia—Etoposide—brain cancer	0.00141	0.0037	CcSEcCtD
L-Arginine—Hypersensitivity—Carmustine—brain cancer	0.00141	0.0037	CcSEcCtD
L-Arginine—Nausea—Hydroxyurea—brain cancer	0.00141	0.00369	CcSEcCtD
L-Arginine—Hypersensitivity—Temozolomide—brain cancer	0.00137	0.00357	CcSEcCtD
L-Arginine—NOS3—VEGFR2 mediated vascular permeability—CTNNB1—brain cancer	0.00134	0.0058	CbGpPWpGaD
L-Arginine—NOS3—Angiogenesis—VEGFA—brain cancer	0.00134	0.00578	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—CYP2C9—brain cancer	0.00131	0.00564	CbGpPWpGaD
L-Arginine—Decreased appetite—Etoposide—brain cancer	0.00129	0.00337	CcSEcCtD
L-Arginine—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—brain cancer	0.00128	0.00555	CbGpPWpGaD
L-Arginine—Vomiting—Carmustine—brain cancer	0.00122	0.00319	CcSEcCtD
L-Arginine—Rash—Carmustine—brain cancer	0.00121	0.00316	CcSEcCtD
L-Arginine—Dermatitis—Carmustine—brain cancer	0.00121	0.00316	CcSEcCtD
L-Arginine—NOS2—IL23-mediated signaling events—STAT3—brain cancer	0.00121	0.00521	CbGpPWpGaD
L-Arginine—Headache—Carmustine—brain cancer	0.0012	0.00314	CcSEcCtD
L-Arginine—ASL—Metabolism—CYP2C9—brain cancer	0.00119	0.00516	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—MPL—brain cancer	0.00119	0.00516	CbGpPWpGaD
L-Arginine—Vomiting—Temozolomide—brain cancer	0.00118	0.00308	CcSEcCtD
L-Arginine—SLC22A5—cerebellum—brain cancer	0.00118	0.00323	CbGeAlD
L-Arginine—Rash—Temozolomide—brain cancer	0.00117	0.00306	CcSEcCtD
L-Arginine—Dermatitis—Temozolomide—brain cancer	0.00117	0.00306	CcSEcCtD
L-Arginine—Headache—Temozolomide—brain cancer	0.00116	0.00304	CcSEcCtD
L-Arginine—NOS3—VEGFR1 specific signals—VEGFA—brain cancer	0.00115	0.00497	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—S100A10—brain cancer	0.00114	0.00494	CbGpPWpGaD
L-Arginine—Nausea—Carmustine—brain cancer	0.00114	0.00298	CcSEcCtD
L-Arginine—NOS3—Thromboxane A2 receptor signaling—PIK3CG—brain cancer	0.00114	0.00491	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—BSG—brain cancer	0.00111	0.0048	CbGpPWpGaD
L-Arginine—Nausea—Temozolomide—brain cancer	0.0011	0.00288	CcSEcCtD
L-Arginine—Hypersensitivity—Etoposide—brain cancer	0.00109	0.00286	CcSEcCtD
L-Arginine—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCND1—brain cancer	0.00109	0.00469	CbGpPWpGaD
L-Arginine—NOS2—IL12-mediated signaling events—RELA—brain cancer	0.00108	0.00467	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—VAV1—brain cancer	0.00107	0.0046	CbGpPWpGaD
L-Arginine—ASL—Metabolism—BSG—brain cancer	0.00102	0.00439	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—VAV1—brain cancer	0.00101	0.00435	CbGpPWpGaD
L-Arginine—NOS2—AGE/RAGE pathway—RELA—brain cancer	0.001	0.00433	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—RELA—brain cancer	0.00099	0.00428	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—CYP2C9—brain cancer	0.000989	0.00428	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—ERBB2—brain cancer	0.000984	0.00425	CbGpPWpGaD
L-Arginine—NOS2—IL12-mediated signaling events—IL2—brain cancer	0.000974	0.00421	CbGpPWpGaD
L-Arginine—NOS3—Angiopoietin receptor Tie2-mediated signaling—RELA—brain cancer	0.000972	0.0042	CbGpPWpGaD
L-Arginine—NOS2—Signaling mediated by p38-alpha and p38-beta—TP53—brain cancer	0.000963	0.00416	CbGpPWpGaD
L-Arginine—NOS2—ATF-2 transcription factor network—CCND1—brain cancer	0.000962	0.00416	CbGpPWpGaD
L-Arginine—SLC22A5—brain—brain cancer	0.000958	0.00262	CbGeAlD
L-Arginine—AZIN2—Metabolism—IDH1—brain cancer	0.000955	0.00412	CbGpPWpGaD
L-Arginine—Vomiting—Etoposide—brain cancer	0.000943	0.00247	CcSEcCtD
L-Arginine—Rash—Etoposide—brain cancer	0.000936	0.00245	CcSEcCtD
L-Arginine—Dermatitis—Etoposide—brain cancer	0.000935	0.00244	CcSEcCtD
L-Arginine—Headache—Etoposide—brain cancer	0.00093	0.00243	CcSEcCtD
L-Arginine—NOS3—Hemostasis—MPL—brain cancer	0.000927	0.004	CbGpPWpGaD
L-Arginine—SLC7A1—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000916	0.00396	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—S100A10—brain cancer	0.000889	0.00384	CbGpPWpGaD
L-Arginine—Nausea—Etoposide—brain cancer	0.000881	0.00231	CcSEcCtD
L-Arginine—ASL—Metabolism—IDH1—brain cancer	0.000873	0.00377	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—S100A10—brain cancer	0.000863	0.00373	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—CTNNB1—brain cancer	0.000861	0.00372	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—CDK4—brain cancer	0.000856	0.0037	CbGpPWpGaD
L-Arginine—SLC7A3—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000851	0.00368	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—S100A10—brain cancer	0.000849	0.00367	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—BSG—brain cancer	0.000841	0.00363	CbGpPWpGaD
L-Arginine—NOS2—IL12-mediated signaling events—STAT3—brain cancer	0.00082	0.00354	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—BSG—brain cancer	0.000806	0.00348	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—RELA—brain cancer	0.000778	0.00336	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—IL2—brain cancer	0.000777	0.00336	CbGpPWpGaD
L-Arginine—NOS2—HIF-1-alpha transcription factor network—VEGFA—brain cancer	0.000767	0.00331	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—VAV1—brain cancer	0.000765	0.0033	CbGpPWpGaD
L-Arginine—NOS2—AGE/RAGE pathway—STAT3—brain cancer	0.00076	0.00328	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—ENO2—brain cancer	0.000755	0.00326	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—STAT3—brain cancer	0.00075	0.00324	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—SIRT1—brain cancer	0.000739	0.00319	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—IDH1—brain cancer	0.000723	0.00313	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—RELA—brain cancer	0.000703	0.00304	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—ERBB2—brain cancer	0.000698	0.00302	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—MYC—brain cancer	0.000697	0.00301	CbGpPWpGaD
L-Arginine—NOS2—AGE/RAGE pathway—EGFR—brain cancer	0.00069	0.00298	CbGpPWpGaD
L-Arginine—ASL—Metabolism—ENO2—brain cancer	0.00069	0.00298	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—CYP2C9—brain cancer	0.000686	0.00296	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—EGFR—brain cancer	0.000682	0.00295	CbGpPWpGaD
L-Arginine—NOS2—Disease—DTX2—brain cancer	0.00068	0.00294	CbGpPWpGaD
L-Arginine—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—CTNNB1—brain cancer	0.000661	0.00285	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—VEGFA—brain cancer	0.00066	0.00285	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—S100A10—brain cancer	0.000649	0.0028	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—BSG—brain cancer	0.000626	0.0027	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—CCND1—brain cancer	0.000617	0.00266	CbGpPWpGaD
L-Arginine—NOS3—Thromboxane A2 receptor signaling—EGFR—brain cancer	0.000611	0.00264	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—PCNA—brain cancer	0.000597	0.00258	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—RELA—brain cancer	0.000597	0.00258	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—EGFR—brain cancer	0.000594	0.00257	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—STAT3—brain cancer	0.00059	0.00255	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—BSG—brain cancer	0.000583	0.00252	CbGpPWpGaD
L-Arginine—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—brain cancer	0.000582	0.00251	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—TP53—brain cancer	0.000573	0.00247	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—ENO2—brain cancer	0.000572	0.00247	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—IL2—brain cancer	0.000567	0.00245	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—CDK4—brain cancer	0.000559	0.00242	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—CCND1—brain cancer	0.000553	0.00239	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—IL2—brain cancer	0.000537	0.00232	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—EGFR—brain cancer	0.000536	0.00232	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—STAT3—brain cancer	0.000532	0.0023	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—TRPC6—brain cancer	0.000528	0.00228	CbGpPWpGaD
L-Arginine—NOS3—Disease—DTX2—brain cancer	0.000528	0.00228	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—CTNNB1—brain cancer	0.000519	0.00224	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—IDH1—brain cancer	0.000501	0.00217	CbGpPWpGaD
L-Arginine—NOS2—Disease—HES5—brain cancer	0.000499	0.00216	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—CTNNB1—brain cancer	0.00046	0.00199	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—MYC—brain cancer	0.000443	0.00192	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—OR4C12—brain cancer	0.000435	0.00188	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—OR14C36—brain cancer	0.000435	0.00188	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—CTNNB1—brain cancer	0.000434	0.00187	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—EGFR—brain cancer	0.000434	0.00187	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—TRPC6—brain cancer	0.00041	0.00177	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—VEGFA—brain cancer	0.000405	0.00175	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000399	0.00172	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—ENO2—brain cancer	0.000396	0.00171	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—VAV1—brain cancer	0.000396	0.00171	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000392	0.00169	CbGpPWpGaD
L-Arginine—NOS3—Disease—HES5—brain cancer	0.000387	0.00167	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—VEGFA—brain cancer	0.000382	0.00165	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—ERBB2—brain cancer	0.000377	0.00163	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—DTX2—brain cancer	0.00037	0.0016	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—TP53—brain cancer	0.000364	0.00157	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—PIK3CG—brain cancer	0.000346	0.0015	CbGpPWpGaD
L-Arginine—NOS2—Disease—IDH1—brain cancer	0.000336	0.00145	CbGpPWpGaD
L-Arginine—NOS2—Disease—HEY1—brain cancer	0.000318	0.00137	CbGpPWpGaD
L-Arginine—ASL—Metabolism—PIK3CG—brain cancer	0.000317	0.00137	CbGpPWpGaD
L-Arginine—NOS2—Disease—DLL1—brain cancer	0.000312	0.00135	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—VAV1—brain cancer	0.000307	0.00133	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—TRPC6—brain cancer	0.0003	0.00129	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CYP2C9—brain cancer	0.000299	0.00129	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—STAT3—brain cancer	0.000288	0.00124	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PTCH2—brain cancer	0.00028	0.00121	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HES5—brain cancer	0.000271	0.00117	CbGpPWpGaD
L-Arginine—NOS2—Disease—SHH—brain cancer	0.000265	0.00115	CbGpPWpGaD
L-Arginine—NOS2—Disease—ENO2—brain cancer	0.000265	0.00115	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—STRADA—brain cancer	0.000263	0.00114	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PIK3CG—brain cancer	0.000262	0.00113	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—EGFR—brain cancer	0.000261	0.00113	CbGpPWpGaD
L-Arginine—NOS3—Disease—IDH1—brain cancer	0.000261	0.00113	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—BSG—brain cancer	0.000254	0.0011	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—PIK3CG—brain cancer	0.000251	0.00109	CbGpPWpGaD
L-Arginine—NOS3—Disease—HEY1—brain cancer	0.000247	0.00107	CbGpPWpGaD
L-Arginine—NOS3—Disease—DLL1—brain cancer	0.000242	0.00105	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—TP53—brain cancer	0.000238	0.00103	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ABR—brain cancer	0.00022	0.00095	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—IDH1—brain cancer	0.000218	0.000943	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GLI2—brain cancer	0.000212	0.000917	CbGpPWpGaD
L-Arginine—NOS3—Disease—ENO2—brain cancer	0.000206	0.00089	CbGpPWpGaD
L-Arginine—NOS3—Disease—SHH—brain cancer	0.000206	0.00089	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GLI1—brain cancer	0.0002	0.000862	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—PIK3CG—brain cancer	0.000195	0.000843	CbGpPWpGaD
L-Arginine—NOS2—Disease—VAV1—brain cancer	0.000192	0.000828	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SUFU—brain cancer	0.000189	0.000817	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GFAP—brain cancer	0.000183	0.000789	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PIK3CG—brain cancer	0.000182	0.000786	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—IL2—brain cancer	0.000177	0.000764	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HEY1—brain cancer	0.000173	0.000748	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ENO2—brain cancer	0.000173	0.000745	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—DLL1—brain cancer	0.00017	0.000733	CbGpPWpGaD
L-Arginine—NOS2—Disease—HES1—brain cancer	0.000165	0.000712	CbGpPWpGaD
L-Arginine—NOS2—Disease—PDGFRA—brain cancer	0.000157	0.000678	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—VEGFA—brain cancer	0.00015	0.00065	CbGpPWpGaD
L-Arginine—NOS3—Disease—VAV1—brain cancer	0.000149	0.000643	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SHH—brain cancer	0.000144	0.000623	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TRPC6—brain cancer	0.000139	0.000601	CbGpPWpGaD
L-Arginine—NOS2—Disease—IRS2—brain cancer	0.000138	0.000595	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—IL2—brain cancer	0.000137	0.000594	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SMO—brain cancer	0.000137	0.000591	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PTCH1—brain cancer	0.000137	0.000591	CbGpPWpGaD
L-Arginine—NOS3—Disease—HES1—brain cancer	0.000128	0.000553	CbGpPWpGaD
L-Arginine—NOS3—Disease—PDGFRA—brain cancer	0.000122	0.000527	CbGpPWpGaD
L-Arginine—NOS2—Disease—APC—brain cancer	0.000122	0.000526	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—VEGFA—brain cancer	0.000117	0.000504	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—TP53—brain cancer	0.000114	0.000491	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NOTCH2—brain cancer	0.000109	0.000472	CbGpPWpGaD
L-Arginine—NOS3—Disease—IRS2—brain cancer	0.000107	0.000462	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—VAV1—brain cancer	0.000104	0.00045	CbGpPWpGaD
L-Arginine—NOS2—Disease—ERBB2—brain cancer	9.45e-05	0.000408	CbGpPWpGaD
L-Arginine—NOS3—Disease—APC—brain cancer	9.45e-05	0.000408	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HES1—brain cancer	8.96e-05	0.000387	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—TP53—brain cancer	8.82e-05	0.000381	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PDGFRA—brain cancer	8.54e-05	0.000369	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SPP1—brain cancer	8.29e-05	0.000358	CbGpPWpGaD
L-Arginine—NOS2—Disease—CTNNB1—brain cancer	8.27e-05	0.000357	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PIK3CG—brain cancer	7.92e-05	0.000342	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IRS2—brain cancer	7.49e-05	0.000324	CbGpPWpGaD
L-Arginine—NOS3—Disease—ERBB2—brain cancer	7.34e-05	0.000317	CbGpPWpGaD
L-Arginine—NOS2—Disease—STAT3—brain cancer	7.21e-05	0.000311	CbGpPWpGaD
L-Arginine—NOS2—Disease—MYC—brain cancer	6.7e-05	0.000289	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PIK3CG—brain cancer	6.62e-05	0.000286	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—APC—brain cancer	6.62e-05	0.000286	CbGpPWpGaD
L-Arginine—NOS2—Disease—EGFR—brain cancer	6.55e-05	0.000283	CbGpPWpGaD
L-Arginine—NOS3—Disease—CTNNB1—brain cancer	6.42e-05	0.000277	CbGpPWpGaD
L-Arginine—NOS3—Disease—STAT3—brain cancer	5.6e-05	0.000242	CbGpPWpGaD
L-Arginine—NOS3—Disease—MYC—brain cancer	5.2e-05	0.000225	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—RELA—brain cancer	5.17e-05	0.000223	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ERBB2—brain cancer	5.14e-05	0.000222	CbGpPWpGaD
L-Arginine—NOS3—Disease—EGFR—brain cancer	5.09e-05	0.00022	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IL2—brain cancer	4.66e-05	0.000201	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCND1—brain cancer	4.54e-05	0.000196	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CTNNB1—brain cancer	4.5e-05	0.000194	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—VEGFA—brain cancer	3.96e-05	0.000171	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—STAT3—brain cancer	3.92e-05	0.000169	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MYC—brain cancer	3.64e-05	0.000157	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—EGFR—brain cancer	3.56e-05	0.000154	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TP53—brain cancer	2.99e-05	0.000129	CbGpPWpGaD
